Biogen's aducanumab raises hope that Alzheimer's can be treated at its source.
Year: 2015
Type: article
Source: PubMed
Author: Krishna Rutvij Patel
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2466470138